Heart failure (HF) is life-threatening disease due to electro-mechanical dysfunction associated with hemodynamic overload, while alterations of extracellular matrix (ECM) along with perturbed connexin-43 (Cx43) might be key factors involved. We aimed to explore a dual impact of pressure, and volume overload due to aorto-caval fistula (ACF) on Cx43 and ECM as well as effect of renin-angiotensin blockade. Hypertensive Ren-2 transgenic rats (TGR) and normotensive Hannover Sprague-Dawley rats (HSD) that underwent ACF were treated for 15-weeks with trandolapril or losartan. Blood serum and heart tissue samples of the right (RV) and left ventricles (LV) were used for analyses. ACF-HF increased RV, LV and lung mass in HSD and to lesser extent in TGR, while treatment attenuated it and normalized serum ANP, BNP-45 and TBARS. Cx43 protein and its ser368 variant along with PKCε were lower in TGR vs HSD and suppressed in both rat strains due to ACF but prevented more by trandolapril. Pro-hypertrophic PKCδ, collagen I and hydroxyproline were elevated in TGR and increased due to ACF in both rat strains. While SMAD2/3 and MMP2 levels were lower in TGR vs HSD and reduced due to ACF in both strains. Findings point out the strain-related differences in response to volume overload. Disorders of Cx43 and ECM signalling may contribute not only to HF but also to the formation of arrhythmogenic substrate. There is benefit of treatment with trandolapril and losartan indicating their pleiotropic anti-arrhythmic potential. It may provide novel input to therapy.

Center for Experimental Medicine Institute for Clinical and Experimental Medicine 140 21 Prague Czech Republic

Centre of Experimental Medicine Institute for Heart Research Slovak Academy of Sciences 841 04 Bratislava Slovakia

Department of Internal Medicine 1 Cardiology University Hospital Olomouc and Palacky University Olomouc Czech Republic

Department of Nephrology 1st Faculty of Medicine Charles University and General University Hospital Prague 128 08 Prague Czech Republic

Zobrazit více v PubMed

Bueno H, Moura B, Lancellotti P, Bauersachs J. The year in cardiovascular medicine 2020: Heart failure and cardiomyopathies. Eur. Heart J. 2021;42:657–670. doi: 10.1093/eurheartj/ehaa1061. PubMed DOI

Boriani G, et al. Sinergy between drugs and devices in the fight against sudden cardiac death and heart failure. Eur. J. Prev. Cardiol. 2021;28:110–123. doi: 10.1093/eurjpc/zwaa015. PubMed DOI

Teramoto K, Tromp J, Lam CSP. Heart failure or heart success? Cardiovasc. Res. 2021;117:E29–E34. doi: 10.1093/cvr/cvab022. PubMed DOI

Notaristefano F, Ambrosio G. Defibrillator and non-ischaemic dilated cardiomyopathy: A never ending story. Eur. Heart J. Suppl. 2019;21:B5–B6. doi: 10.1093/eurheartj/suz005. PubMed DOI PMC

Rohr S. Arrhythmogenic implications of fibroblast-myocyte interactions. Circ. Arrhythmia Electrophysiol. 2012;5:442–452. doi: 10.1161/CIRCEP.110.957647. PubMed DOI

Tribulova N, et al. Omega-3 index and anti-arrhythmic potential of omega-3 PUFAs. Nutrients. 2017;9:1–21. doi: 10.3390/nu9111191. PubMed DOI PMC

Guglielmo M, Pontone G. Risk stratification in cardiomyopathies (dilated, hypertrophic, and arrhythmogenic cardiomyopathy) by cardiac magnetic resonance imaging. Eur. Hear. J. Suppl. 2021;23:E118–E122. doi: 10.1093/eurheartj/suab105. PubMed DOI PMC

Dupont E, et al. Altered connexin expression in human congestive heart failure. J. Mol. Cell. Cardiol. 2001;33:359–371. doi: 10.1006/jmcc.2000.1308. PubMed DOI

Kostin S, et al. Gap junction remodeling and altered connexin43 expression in the failing human heart. Mol. Cell. Biochem. 2003;242:135–144. doi: 10.1023/A:1021154115673. PubMed DOI

Benes J, et al. Myocardial morphological characteristics and proarrhythmic substrate in the rat model of heart failure due to chronic volume overload. Anat. Rec. 2011;294:102–111. doi: 10.1002/ar.21280. PubMed DOI

Tribulova N, Szeiffova Bacova B, Benova T, Viczenczova C. Can we protect from malignant arrhythmias by modulation of cardiac cell-to-cell coupling? J. Electrocardiol. 2015;48:434–440. doi: 10.1016/j.jelectrocard.2015.02.006. PubMed DOI

Sedmera D, et al. Changes in myocardial composition and conduction properties in rat heart failure model induced by chronic volume overload. Front. Physiol. 2016;7:1–12. doi: 10.3389/fphys.2016.00367. PubMed DOI PMC

Andelova K, et al. Cardiac connexin-43 hemichannels and pannexin1 channels: Provocative antiarrhythmic targets. Int. J. Mol. Sci. 2021;22:1–22. PubMed PMC

Herum KM, Lunde IG, McCulloch AD, Christensen G. The soft- and hard-heartedness of cardiac fibroblasts: Mechanotransduction signaling pathways in fibrosis of the heart. J. Clin. Med. 2017;6:53. doi: 10.3390/jcm6050053. PubMed DOI PMC

Guggilam A, et al. In vivo and in vitro cardiac responses to beta-adrenergic stimulation in volume-overload heart failure. J. Mol. Cell. Cardiol. 2013;57:47–58. doi: 10.1016/j.yjmcc.2012.11.013. PubMed DOI PMC

Sykora M, et al. Cardiac cx43 and ECM responses to altered thyroid status are blunted in spontaneously hypertensive versus normotensive rats. Int. J. Mol. Sci. 2019;20:3758. doi: 10.3390/ijms20153758. PubMed DOI PMC

Bacova BS, et al. Antiarrhythmic effects of melatonin and omega-3 are linked with protection of myocardial cx43 topology and suppression of fibrosis in catecholamine stressed normotensive and hypertensive rats. Antioxidants. 2020;9:1–19. PubMed PMC

Bacova BS, et al. Suppression of β1-adrenoceptor autoantibodies is involved in the antiarrhythmic effects of omega-3 fatty acids in male and female hypertensive rats. Int. J. Mol. Sci. 2020;21:526. doi: 10.3390/ijms21020526. PubMed DOI PMC

Lucero CM, et al. Cardiac remodeling and arrhythmogenesis are ameliorated by administration of Cx43 mimetic peptide Gap27 in heart failure rats. Sci. Rep. 2020;10:1–12. doi: 10.1038/s41598-020-63336-6. PubMed DOI PMC

Martins-Marques T, et al. EHD1 modulates Cx43 gap junction remodeling associated with cardiac diseases. Circ. Res. 2020 doi: 10.1161/CIRCRESAHA.119.316502. PubMed DOI

Langheinrich M, et al. The hypertensive Ren-2 transgenic rat TGR (mREN2)27 in hypertension research: Characteristics and functional aspects. Am. J. Hypertens. 1996;9:506–512. doi: 10.1016/0895-7061(95)00400-9. PubMed DOI

Belkin MN, et al. Postoperative tolvaptan use in left ventricular assist device patients: The TOLVAD randomized pilot study. Artif. Organs. 2022;46:2382–2390. doi: 10.1111/aor.14375. PubMed DOI PMC

Ameri P, et al. Novel basic science insights to improve the management of heart failure: Review of the working group on cellular and molecular biology of the heart of the Italian Society of Cardiology. Int. J. Mol. Sci. 2020;21:1192. doi: 10.3390/ijms21041192. PubMed DOI PMC

Kratky V, et al. AT1 receptor blocker, but not an ACE inhibitor, prevents kidneys from hypoperfusion during congestive heart failure in normotensive and hypertensive rats. Sci. Rep. 2021;11:4271. doi: 10.1038/s41598-021-83906-6. PubMed DOI PMC

Kratky V, et al. AT1 receptor blocker, but not an ACE inhibitor, prevents kidneys from hypoperfusion during congestive heart failure in normotensive and hypertensive rats. Sci. Rep. 2021;11:1–15. doi: 10.1038/s41598-021-83906-6. PubMed DOI PMC

Kala P, et al. Endothelin type A receptor blockade attenuates aorto-caval fistula-induced heart failure in rats with angiotensin II-dependent hypertension. J. Hypertens. 2023;41:99–114. doi: 10.1097/HJH.0000000000003307. PubMed DOI PMC

Wang XH, et al. Improvement of cardiac function and reversal of gap junction remodeling by neuregulin-1β in volume-overloaded rats with heart failure. J. Geriatr. Cardiol. 2012;9:172–179. doi: 10.3724/SP.J.1263.2012.03271. PubMed DOI PMC

Magga J, Vuolteenaho O, Tokola H, Marttila M, Ruskoaho H. B-type natriuretic peptide: A myocyte-specific marker for characterizing load-induced alterations in cardiac gene expression. Ann. Med. 1998;30:39–45. PubMed

Yancey DM, et al. Cardiomyocyte mitochondrial oxidative stress and cytoskeletal breakdown in the heart with a primary volume overload. Am. J. Physiol. Heart Circ. Physiol. 2015;308:H651–H663. doi: 10.1152/ajpheart.00638.2014. PubMed DOI PMC

Ulasova E, et al. Loss of interstitial collagen causes structural and functional alterations of cardiomyocyte subsarcolemmal mitochondria in acute volume overload. J. Mol. Cell. Cardiol. 2011;50:147–156. doi: 10.1016/j.yjmcc.2010.10.034. PubMed DOI PMC

Jarkovská D, et al. Effects of trandolapril on structural, contractile and electrophysiological remodeling in experimental volume overload heart failure. Front. Pharmacol. 2021;12:1–13. doi: 10.3389/fphar.2021.729568. PubMed DOI PMC

Havlenova T, et al. Right versus left ventricular remodeling in heart failure due to chronic volume overload. Sci. Rep. 2021;11:8. doi: 10.1038/s41598-021-96618-8. PubMed DOI PMC

El Hajj EC, El Hajj MC, Ninh VK, Gardner JD. Inhibitor of lysyl oxidase improves cardiac function and the collagen/MMP profile in response to volume overload. Am. J. Physiol. Heart Circ. Physiol. 2018;315:H463–H473. doi: 10.1152/ajpheart.00086.2018. PubMed DOI PMC

Shaqura M, et al. Pathological alterations in liver injury following congestive heart failure induced by volume overload in rats. PLoS ONE. 2017;12:e0184161. doi: 10.1371/journal.pone.0184161. PubMed DOI PMC

Anker SD, Coats AJS. Cardiac cachexia. Chest. 1999;115:836–847. doi: 10.1378/chest.115.3.836. PubMed DOI

Mitašíková M, et al. Aged male and female spontaneously hypertensive rats benefit from n-3 polyunsaturated fatty acids supplementation. Physiol. Res. 2008;57:S39. doi: 10.33549/physiolres.931550. PubMed DOI

Sykora M, et al. Alterations in myocardial connexin-43 and matrix metalloproteinase-2 signaling in response to pregnancy and oxygen deprivation of wistar rats: A pilot study. Can. J. Physiol. Pharmacol. 2019;97:829–836. doi: 10.1139/cjpp-2018-0740. PubMed DOI

Heusch G. Coronary blood flow in heart failure: Cause, consequence and bystander. Basic Res. Cardiol. 2022;117:1. doi: 10.1007/s00395-022-00909-8. PubMed DOI PMC

Andelova K, et al. Cardiac Cx43 signaling is enhanced and TGF-β1/SMAD2/3 suppressed in response to cold acclimation and modulated by thyroid status in hairless SHRM. Biomedicines. 2022;10:1707. doi: 10.3390/biomedicines10071707. PubMed DOI PMC

Kohutova J, et al. Anti-arrhythmic cardiac phenotype elicited by chronic intermittent hypoxia is associated with alterations in connexin-43 expression, phosphorylation, and distribution. Front. Endocrinol. 2019;10:1–10. PubMed PMC

Bruce AF, Rothery S, Dupont E, Severs NJ. Gap junction remodelling in human heart failure is associated with increased interaction of connexin43 with ZO-1. Cardiovasc. Res. 2008;77:757–765. doi: 10.1093/cvr/cvm083. PubMed DOI PMC

Seidel T, Salameh A, Dhein S. A simulation study of cellular hypertrophy and connexin lateralization in cardiac tissue. Biophys. J. 2010;99:2821–2830. doi: 10.1016/j.bpj.2010.09.010. PubMed DOI PMC

Bacova BS, et al. Does myocardial atrophy represent anti-arrhythmic phenotype? Biomedicines. 2022;10:2819. doi: 10.3390/biomedicines10112819. PubMed DOI PMC

Chen X, Zhang Y. Myocardial Cx43 expression in the cases of sudden death due to dilated cardiomyopathy. Forensic Sci. Int. 2006;162:170–173. doi: 10.1016/j.forsciint.2006.06.044. PubMed DOI

Díez J, De Boer RA. Management of cardiac fibrosis is the largest unmet medical need in heart failure. Cardiovasc. Res. 2022;118:E20–E22. doi: 10.1093/cvr/cvab228. PubMed DOI

Maruyama K, Imanaka-Yoshida K. The pathogenesis of cardiac fibrosis: A review of recent progress. Int. J. Mol. Sci. 2022;23:2617. doi: 10.3390/ijms23052617. PubMed DOI PMC

Childers RC, et al. Role of the cytoskeleton in the development of a hypofibrotic cardiac fibroblast phenotype in volume overload heart failure. Am. J. Physiol. Heart Circ. Physiol. 2019;316:H596–H608. doi: 10.1152/ajpheart.00095.2018. PubMed DOI

Childers RC, Lucchesi PA, Gooch KJ. Decreased substrate stiffness promotes a hypofibrotic phenotype in cardiac fibroblasts. Int. J. Mol. Sci. 2021;22:6231. doi: 10.3390/ijms22126231. PubMed DOI PMC

Sovari AA, et al. Inhibition of c-Src tyrosine kinase prevents angiotensin II-mediated connexin-43 remodeling and sudden cardiac death. J. Am. Coll. Cardiol. 2011;58:2332–2339. doi: 10.1016/j.jacc.2011.07.048. PubMed DOI PMC

Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8:e1000412. doi: 10.1371/journal.pbio.1000412. PubMed DOI PMC

du Sert NP, et al. The arrive guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol. 2020;18:e3000410. doi: 10.1371/journal.pbio.3000410. PubMed DOI PMC

Červenka L, et al. Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula. Clin. Exp. Pharmacol. Physiol. 2015;42:795–807. doi: 10.1111/1440-1681.12419. PubMed DOI

Szobi A, et al. Cardioprotection of ischaemic preconditioning is associated with inhibition of translocation of MLKL within the plasma membrane. J. Cell. Mol. Med. 2018;22:4183–4196. doi: 10.1111/jcmm.13697. PubMed DOI PMC

Shlafer M, Shepard BM. A method to reduce interference by sucrose in the detection of thiobarbituric acid-reactive substances. Anal. Biochem. 1984;137:269–276. doi: 10.1016/0003-2697(84)90084-8. PubMed DOI

Ivanová M, et al. Chronic cardiotoxicity of doxorubicin involves activation of myocardial and circulating matrix metalloproteinases in rats. Acta Pharmacol. Sin. 2012;33:459–469. doi: 10.1038/aps.2011.194. PubMed DOI PMC

Benova T, et al. Melatonin attenuates hypertension-related proarrhythmic myocardial maladaptation of connexin-43 and propensity of the heart to lethalarrhythmias. Can. J. Physiol. Pharmacol. 2013;91:633–639. doi: 10.1139/cjpp-2012-0393. PubMed DOI

Lojda Z, Gossrau R, Schiebler TH. Enzyme histochemistry. Enzym. Histochem. 1979 doi: 10.1007/978-3-642-67234-7. DOI

Effects of renal denervation on the course of cardiorenal syndrome: insight from studies with fawn-hooded hypertensive rats